ArticleFrontiers in oncology2021

Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma.

Hongjin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.